By Julie Steenhuysen, Siddhi Mahatole and Mariam Sunny May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its ...

The company confirmed early-stage hantavirus research as a WHO-confirmed outbreak grows, while flu vaccine data published in ...

Regulatory filings are under review in the U.S., Europe, Canada and Australia, with potential approvals expected to ...

Australia’s medicines regulator has confirmed it is evaluating a low dose for children as young as six-months-old.

Moderna reported positive Phase 3 results for its mRNA seasonal influenza vaccine candidate, mRNA-1010, showing stronger ...

Australia has reached a supply agreement for 25 million doses of Moderna COVID-19 vaccines in a deal that the government hopes will ensure all Australian adults have access to inoculation this year.

While U.S. policymakers are scaling back funding on mRNA vaccine research, Australia is accelerating investment in the technology. At the center of this effort is Moderna Inc., which is establishing ...